These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8011388

  • 21. FLASH: clinical three-dimensional magnetic resonance imaging.
    Runge VM, Wood ML, Kaufman DM, Nelson KL, Traill MR.
    Radiographics; 1988 Sep; 8(5):947-65. PubMed ID: 3227132
    [Abstract] [Full Text] [Related]

  • 22. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P, Larsson EM, Kristoffersen DT, Jonsson E, Holtås S.
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Non-enhancing supratentorial malignant astrocytomas: MR features and possible mechanisms.
    Mihara F, Numaguchi Y, Rothman M, Kristt D, Fiandaca M, Swallow L.
    Radiat Med; 1995 May; 13(1):11-7. PubMed ID: 7597198
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Time-dependency in brain lesion enhancement with gadodiamide injection.
    Akeson P, Nordström CH, Holtås S.
    Acta Radiol; 1997 Jan; 38(1):19-24. PubMed ID: 9059396
    [Abstract] [Full Text] [Related]

  • 30. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
    Chang KH, Ra DG, Han MH, Cha SH, Kim HD, Han MC.
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
    [Abstract] [Full Text] [Related]

  • 31. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, Harsh GR, Niemi PT, Weisskoff RM, Rosen BR.
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR, Mansfield P, Gowland P, Worthington BS, Firth JL.
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise.
    Benner T, Heiland S, Erb G, Forsting M, Sartor K.
    Magn Reson Imaging; 1997 Jun; 15(3):307-17. PubMed ID: 9201678
    [Abstract] [Full Text] [Related]

  • 38. Inverse correlation between T1 relaxation times before and after administration of contrast media in malignant brain tumors.
    Niemi P, Aronen HJ, Kwong KK, Gazit IE, Pardo FS, Rosen BR.
    Acad Radiol; 1996 Aug; 3 Suppl 2():S286-8. PubMed ID: 8796582
    [No Abstract] [Full Text] [Related]

  • 39. [The use of hyperventilation for improving the visualization of glial tumors of the brain in magnetic resonance tomography using the contrast substance Gd-DTPA].
    Pronin IN, Kornienko VN, Petriaĭkin AV, Golanov AV.
    Zh Vopr Neirokhir Im N N Burdenko; 1995 Aug; (3):10-3. PubMed ID: 7483947
    [Abstract] [Full Text] [Related]

  • 40. Gd-DTPA: an i.v. contrast agent for clinical MRI.
    Runge VM.
    Int J Rad Appl Instrum B; 1988 Aug; 15(1):37-44. PubMed ID: 3280522
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.